Higher Body Fat Linked to Higher Risk of Death From Prostate Cancer
Increases in waist-to-hip ratio, body mass index, waist circumference, and total body fat percentage were associated with increases in the risk of prostate cancer death.
Increases in waist-to-hip ratio, body mass index, waist circumference, and total body fat percentage were associated with increases in the risk of prostate cancer death.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
The median time to definitive deterioration was longer with lenvatinib-pembrolizumab than with sunitinib.
Measuring lymphocytes during or after radiotherapy could provide useful information about infection risk, according to researchers.
Patients who had sarcopenia and an elevated neutrophil-to-lymphocyte ratio had the worst overall survival.
Patients who had high baseline troponin T levels had a more than 3-fold greater risk of MACE.
Researchers assessed pain and HRQOL measures with olaparib vs physician’s choice of treatment in patients with prostate cancer.
The 5-year metastasis-free survival was similar with trimodal therapy and radical cystectomy.
New findings could inform personalized therapeutic strategies for patients with renal cell carcinoma, according to investigators.
The median progression-free survival was similar between the treatment arms.